Molecules/OFATUMUMAB

OFATUMUMAB

Molecular Identity

AntibodyApprovedFirst approved 2009

Mechanism of action: B-lymphocyte antigen CD20 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

2F2ARZERRAGSK-1841157GSK1841157GSKI841157HUMAX-CD20HUMAX-CD20 2F2HUMAX-CD20, 2F2HUMAX-CD20-2F2KESIMPTAOFATUMUMAB

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to OFATUMUMAB

Loading drug network...